Viral vectors and their use for treating hyperproliferative diso

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4351723, 4353201, 435325, 435375, 514 44, 536 235, A61K 3576, A61K 4800, C12N 1586, C12N 1563

Patent

active

058515216

ABSTRACT:
The present invention relates to replication defective recombinant viruses which contain at least one inserted gene encoding all or part of the protein GAX or of a variant of this protein, and to their therapeutic use, in particular for treating post-angioplastic restenosis.

REFERENCES:
patent: 4797368 (1989-01-01), Carter et al.
patent: 4861719 (1989-08-01), Miller
patent: 5139941 (1992-08-01), Muzyezka et al.
patent: 5252479 (1993-10-01), Srivastava
Gorski et al., "Mitogen-responsive nuclear factors that mediate growth control signals in vascular myocytes", Cardiovacular Research 30: 585-592, 1995.
Riessen et al., Percutaneous arterial gene transfer using pure DNA applied to a hydrogel-coated angioplasty balloon, Eur. Heart J., 14, abstract 590, 78 (1993).
Gorski et al., Molecular Cloning of a Diverged Homeobox Gene That Is Rapidly Down-Regulated During the G0/G1 Transition in Vasculat Smooth Muscle Cells, Molecular & Cellular Biol., 13(6), 3722-3733 (1993).
LaPage et al., Molecular Cloning and Localization of the Human GAX Gene to 7p21, Genomics 24, 535-540 (1994).
Gorski et al., Mitogen-responsive nuclear factors that mediate growth control signals in vascular myocytes, Cardiovascular Research 30, 585-592 (1995).
Branellec et al., A Recombinant Adenovirus Encoding Gax can Efficiently Block Vascular Smooth Muscle Cell Proliferation, Supplement Circulation, 92(8), abstract 3041, 1634 (1995).
Walsh et al., Cell Cycle Control by the Gax Homeobox Protein in Vascular Smooth Muscle Cells, Circulation, 90, abstract 3420, 1635 (1994).
Weir et al., Gax is Rapidly Downregulated in Rat Carotid Arteries Following Balloon Injury: In Vivo Demonstration of a Growth-Arrest Transcription Factor, Circulation, 90, abstract 2747, 1511 (1994).
Riessen et al., Prospects for Site-Specific Delivery of Pharmacologic and Molecular Therapies, JACC 23(5), 1234-1244 (1994).
McCormick, Human Gene Therapy: The First Round, Bio/Technology 3(8) 689-693 (1985).
Bender et al., Evidence that the Packaging Signal of Moloney Murine Leukemia Virus Extends into the gag Region, Journal of Virology, 61(5) 1639-1646 (1987).
Cowled et al., Expression of Growth Arrest-Specific (gas) Genes in Senescent Murine Cells, Experimental Cell Research, 211 197-202 (1994).
Jackman et al., Genotoxic Stress Confers Preferential and Coordinate Messenger RNA Stability on the Five gadd Genes, Cancer Research, 54, 5656-5662 (1994).
Brancolini et al., Phosphorylation of the Growth Arrest-specific Protein Gas2 Is Coupled to Actin Rearrangements during Go G1 Transition in NIH 3T3 Cells, The Journal of Cell Biology, 124(5) 743-756 (1994).
Biro et al., In Vitro Effects of a Recombinant Toxin Targeted to the Fibroblast Growth Factor Receptor on Rat Vascular Smooth Muscle and Endothelial Cells, Circulation Research, 71(3) 640-645 (1992).
March et al., 8-Methoxypsoralen and Longwave Ultraviolet Irradiation Are a Novel Antiproliferative Combination for Vascular Smooth Muscle, Circulation 87(1) 184-191 (1993).
Krumlauf, Hox Genes in Vertebrate Development, Cell, 78 191-201 (1994).
Lawrence et al., Homeobox Genes: Their Function in Drosphila Segmentation and Pattern Formation, Cell 78, 181-189 (1994).
Gehring et al., Homeodomain-DNA Recognition, Cell, 78 211-223 (1994).
Del Sal et al., The Growth Arrest-Specific Gene, gas1, Is Involved in Growth Suppression, Cell, 70, 595-607 (1992).
Schneider et al., Genes Specifically Expressed at Growth Arrest of Mammalian Cells, Cell, 54, 787-793 (1988).
Ferrero et al., Estrogen-Regulated Expression of a Growth Arrest Specific Gene (gas-1) in Rat Uterus, Cell Biology International, 17(9) 857-862 (1993).
Pickering et al., Prevention of Smooth Muscle Cell Outgrowth from Human Atherosclerotic Plaque by a Recombinant Cytotoxin Specific for the Epidermal Growth Factor Receptor, Journal of Clinical Investment 91, 724-729 (1993).
Casscells et al., Elimination of smooth muscle cells in experimental restenosis: Targeting of fibroblast growth factor receptors, Proc. Natl. Acad. Sci.USA 89, 7159-7163 (1992).
Zahn et al., Induction of Cellular p53 Activity by DNA-Damaging Agents and Growth Arrest, Molecular & Cellular Biology, 13(7), 4242-4250 (1993).
Coccia et al., Regulation and Expression of a Growth Arrest-Specific Gene (gas5) during Growth, Differentiation, and Development, Molecular & Cellular Biology 12(8), 3514-3521 (1992).
Ferrero et al., Expression of a Growth Arrest Specific Gene (gas-6) During Liver Regeneration: Molecular Mechanisms and Signalling Pathways, Journal of Cellular Physiology 158, 263-269 (1994).
Bernstein et al., Gene Transfer With Retrovirus Vectors, Genetic Enginer, 7, 235-261 (1985).
Graham et al., Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5, J. Gen. Virol., 36, 59-72 (1977).
Graham, Covalently Closed Circles of Human Adenovirus DNA and Infections, The EMBO Journal, 3(12), 2917-2922 (1984).
Levero et al., Defective and Nondefective Adenovirus Vectors for Expressing Foreign Genes In Vitro and In Vivo, Gene, 101, 195-202 (1991).
Beard et al., Transcription Mapping of Mouse Adenovirus Type 1 Early Region 3, Virology, 175, 81-90 (1990).
Lemarchand et al (1993) Circular on Research 72: 1132-1138.
Marshall E (1995) Science 269: 1050-1055.
Miller et al (1995) FASEB J. 9: 190-199.
Berkner, K.L. (1988) Biotechniques 6: 616-629.
Isner, J. M. (1994) The Lancet 344: 1653-1654.
Brinster et al (1988) Proc. Natl. Acad. Sci. USA 85: 836-840.
Riessen et al (1994) J. Am. Coll. Cardiol. 23: 1234-1244.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Viral vectors and their use for treating hyperproliferative diso does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Viral vectors and their use for treating hyperproliferative diso, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral vectors and their use for treating hyperproliferative diso will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2043281

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.